2025-2034 Anti-Inflammatory Therapeutics Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Anti-Inflammatory Therapeutics Market Size By 2025?
In the past few years, the market size of anti-inflammatory therapeutics has seen a consistent increase. It is projected to rise from $114.71 billion in 2024 to $117.28 billion in 2025, marking a compound annual growth rate (CAGR) of 2.2%. This growth during the historical period can be linked to factors such as the high prevalence of chronic diseases, an aging global population, heightened awareness, and relevant government programs.

How Big Is the Anti-Inflammatory Therapeutics Market Size Expected to Grow by 2029?
The market size for anti-inflammatory therapeutics is predicted to experience consistent growth in the coming years, reaching an estimated worth of $142.15 billion in 2029 with a compound annual growth rate (CAGR) of 4.9%. This predicted growth in the forecast period can be credited to pioneering therapies, augmented healthcare spending, concentration on uncommon diseases, biologics, and biosimilars. Noteworthy trends in the forecast period consist of progress in immunotherapy, the implementation of artificial intelligence (AI) and machine learning (ML) in drug discovery, and the broadening of indications.

View the full report here:
https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Key Market Drivers Powering Anti-Inflammatory Therapeutics Market Expansion and Growth?
The surge in cases of inflammatory bowel disease is anticipated to boost the expansion of the anti-inflammatory therapeutics market in the future. Inflammatory bowel disease (IBD) is a long-term health condition that leads to the inflammation of the gastrointestinal tract. Anti-inflammatory therapeutics are critical in the treatment of Crohn's disease as they lower inflammation, control the disease's symptoms, and lessen the probability of surgery. For example, data from Oxford University Press (OUP), the publishing department of the University of Oxford, from July 2023 shows an incidence rate of inflammatory bowel disease (IBD) of 10.9 per 100,000 person-years, and a prevalence rate of 721 per 100,000 individuals. As such, the rise in the number of inflammatory bowel disease cases contributes to the growth of the anti-inflammatory therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

Which Emerging Trends Are Transforming the Anti-Inflammatory Therapeutics Market in 2025?
Key players in the anti-inflammatory therapeutics market are rolling out novel drugs to bolster their market dominance. For instance, in February 2023, Regeneron Pharmaceuticals Inc., an American biotech firm, and Sanofi, a pharmaceutical and healthcare firm based in France, introduced Kevzara (sarilumab). This is the first and unique anti-inflammatory biologic suggested for adult patients with polymyalgia rheumatic (PMR), an inflamed rheumatic condition, who aren't responding sufficiently to corticosteroids or are unable to sustain corticosteroid tapering.

What Are the Emerging Segments in the Anti-Inflammatory Therapeutics Market?
The anti-inflammatory therapeutics market covered in this report is segmented -

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, ket*oprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Who Are the Global Leaders in the Anti-Inflammatory Therapeutics Market?
Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

Which are the Top Profitable Regional Markets for the Anti-Inflammatory Therapeutics Industry?
North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.